Top 3 Healthcare Insights of 2020

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

This week Kevin Stevenson takes a look back at the biggest developments in healthcare and highlights some of his favorite interviews from 2020.

How Healthcare Will Navigate Virtual Hiring Longterm

Prior to March of 2020, Oliver Esman, Managing Partner, Strawn Arnold & Associates did the vast majority of his recruiting work face to face. Today, Esman reports that 95% of their recruiting work is done virtually. “I spend my life on Teams and Zoom and FaceTime and people are adapting to it. You know, I think before people were worried that they were missing something on a virtual interview, missing the personality, not getting all the information, really getting a true sense of the candidate. And that’s just people have gotten more comfortable with doing things virtually,” Esman said.

 

How Health Agencies Can Enhance Remote Care Communication

Midha detailed how the company started in 2008 on the day after Steve Careers announced the Apple app store. Since then, Bottle Rocket has worked with leading healthcare providers to improve their patient journey, efforts that culminated with the creation of the highest-paid patient app in the country with a 4.8 rating in the app store.

 

Health in A Rock ‘n’ Roll World with Jaret Reddick of Bowling for Soup

Jaret takes Kevin through his long battle with depression, including the struggle of just talking about it out in the open, and the effect it was having on him while he was on the road touring. “You never know what somebody is dealing with internally.” Jaret notes that, while he was initially afraid of what people would say when he revealed his internal struggles, the reaction he gets more than anything is gratitude for his willingness to speak on it.

Listen to Previous Episodes of MarketScale’s I Don’t Care Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More